Drugs / Licarbazepine
Licarbazepine
Trials 8
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT00424671 | Nov 2006 → ? | — | Novartis | Completed | No outcome recorded |
| Phase 1 | NCT00426036 | Jun 2006 → ? | — | Novartis | Completed | No outcome recorded |
| Phase 35 trials | ||||||
| Phase 3 | NCT00228059 | Jan 2005 → Jul 2007 | bipolar I disorder | Novartis | Completed | No outcome recorded |
| Phase 3 | NCT00238485 | Jan 2005 → Jul 2007 | bipolar I disorder | Novartis | Completed | No outcome recorded |
| Phase 3 | NCT00107939 | Nov 2004 → Apr 2007 | bipolar disorder | Novartis Pharmaceuticals | Completed | No outcome recorded |
| Phase 3 | NCT00099229 | Nov 2004 → Aug 2006 | bipolar disorder | Novartis Pharmaceuticals | Completed | No outcome recorded |
| Phase 3 | NCT00107926 | Oct 2004 → Aug 2007 | bipolar disorder | Novartis Pharmaceuticals | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT00139594 | Dec 2004 → Jul 2007 | bipolar disorder | Novartis | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 9 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Licarbazepine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00238485 ↗ |
| Known as | 10-hydroxy-carbamazepine | ChEMBL registry synonym — accepted as the source's own label CHEMBL1067 ↗ |
| Known as | Licarbazepina | ChEMBL registry synonym — accepted as the source's own label CHEMBL1067 ↗ |
| Modality | Small molecule | — CHEMBL1067 ↗ |
| Route | Oral | “single oral administration” NCT00424671 ↗ |